Dow Up 0.12% Nasdaq Up 1.35%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.80 0.36(6.62%) Oct 20, 4:00PM EDT
Prev Close:5.44
Open:5.48
Bid:5.61 x 100
Ask:5.94 x 200
1y Target Est:8.72
Beta:1.38
Next Earnings Date: 5-Nov-14ARIA Earnings announcement
Day's Range:5.44 - 5.86
52wk Range:2.15 - 9.83
Volume:8,130,391
Avg Vol (3m):7,436,660
Market Cap:1.08B
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARIA

Comparison

Symbol% ChgMkt Cap
ARIAUp 6.62%1.08B
NVS213.26B
PFE177.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback